ISSN (print) 1726-9806     ISSN (online) 1818-474X
No. 1 (2025), CLINICAL GUIDELINES
No. 1 (2025)
CLINICAL GUIDELINES

Cardiogenic shock. Guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists”

Published 31.01.2025
Evgeny V. Grigoryev
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
https://orcid.org/0000-0001-8370-3083
A.E. Bautin
Almazov National Medical Research Centre, St. Petersburg, Russia
https://orcid.org/0000-0001-5031-7637
M.Yu. Kirov
Northern State Medical University, Arkhangelsk, Russia
https://orcid.org/0000-0002-4375-3374
D.L. Shukevich
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
https://orcid.org/0000-0001-5708-2463
R.A. Kornelyuk
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
https://orcid.org/0000-0002-2654-2727
M.V. Ketskalo
National Medical Research Center Obsterics, Gynecology and Perinatology the name of Academician V.I. Kulakov, Moscow, Russia
https://orcid.org/0000-0001-6569-2106
A.E. Levit
Sverdlovsk Regional Clinical Hospital No 1, Yekaterinburg, Russia
https://orcid.org/0000-0002-9112-1259
S.M. Efremov
Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia
https://orcid.org/0000-0001-5581-9169
M.A. Babaev
Petrovsky National Research Centre of Surgery, Moscow, Russia
https://orcid.org/0000-0002-4288-3791
A.A. Piontek
Sverdlovsk Regional Clinical Hospital No 1, Yekaterinburg, Russia
https://orcid.org/0009-0001-3596-2926
PDF_2025-1-7-31 (Russian)
HTML_2025-1_7-31_S (Russian)

Keywords

cardiogenic shock
recommendation
myocardial dysfunction
microcirculation disorder
biomarkers
inotropic and vasopressor drugs
oxygenation
mechanical support

How to Cite

Grigoryev E.V., Bautin A.E., Kirov M.Y., Shukevich D.L., Kornelyuk R.A., Ketskalo M.V., Levit A.E., Efremov S.M., Babaev M.A., Piontek A.A. Cardiogenic shock. Guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists”. Annals of Critical Care. 2025;(1):7–31. doi:10.21320/1818-474X-2025-1-7-31.
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA ГОСТ

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Statistics

Annotation views: 21735
PDF_2025-1-7-31 (Russian) downloads: 9905
HTML_2025-1_7-31_S (Russian) downloads: 373

Language

English Русский

Most reader

Social Networks

Keywords

Abstract

INTRODUCTION: Cardiogenic shock (CS) is a critical tissue hypoperfusion with a mismatch between oxygen supply and consumption due to a significant decrease in cardiac output caused by acute dysfunction of one or both ventricles of the heart. Acute coronary syndrome is considered the most common cause of CS. OBJECTIVE: To create structured clinical guidelines for cardiogenic shock. MATERIALS AND METHODS: The article presents recommendations for cardiogenic shock in accordance with the scale of assessment of the levels of evidence (LLE) and the scale of assessment of the levels of recommendation (LR). RESULTS: The recommendations provide data on the epidemiology of CS, classification of shock by stages, diagnosis of shock taking into account the importance of hypoperfusion as the leading syndrome of CS and data on the method of primary intensive care, the choice of inotropic and vasopressor therapy, maintenance of oxygenation and features of mechanical circulatory support. CONCLUSIONS: The present clinical guidelines can be used to implement intensive care for CS in adult patients.

PDF_2025-1-7-31 (Russian)
HTML_2025-1_7-31_S (Russian)

Full-text of the article is available for this locale: Russian.

References

  1. van Diepen S., Katz J.N., Albert N.M., et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017; 136(16): e232-e268. DOI: 10.1161/CIR.0000000000000525
  2. Baran D.A., Grines C.L., Bailey S., et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019; 94(1): 29–37. DOI: 10.1002/ccd.28329
  3. Zeymer U., Bueno H., Granger C.B., et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020; 9(2): 183–97. DOI: 10.1177/2048872619894254
  4. Григорьев Е.В., Баутин А.Е., Киров М.Ю. и др. Кардиогенный шок при остром коронарном синдроме: современное состояние проблемы диагностики и интенсивной терапии. Вестник интенсивной терапии им. А.И. Салтанова. 2020; 2: 73–85 DOI: 10.21320/1818-474X-2020-2-73-85 [Grigoryev E.V., Bautin A.E., Kirov M.Yu., et al. Cardiogenic shock associated with acute coronary syndrome: the current state of the problem of diagnostics and intensive care. Article. Annals of Critical Care. 2020; 2: 73–85 (In Russ)
  5. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003; 107(24): 2998–3002. DOI: 10.1161/01.CIR.0000075927.67673.F2
  6. Zweck E., Thayer K.L., Helgestad O.K.L., et al. Phenotyping Cardiogenic Shock. J Am Heart Assoc. 2021; 10(14): e020085. DOI:10.1161/JAHA.120.020085
  7. Buckel M., Maclean P., Knight J.C., et al. Extending the 'host response' paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities. Crit Care. 2023; 27(1): 460. DOI: 10.1186/s13054-023-04752-8
  8. Kohsaka S., Menon V., Lowe A.M., et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005; 165(14): 1643–50. DOI: 10.1001/archinte.165.14.1643
  9. Laghlam D., Benghanem S., Ortuno S., et al. Management of cardiogenic shock: a narrative review. Ann Intensive Care. 2024; 14(1): 45. DOI: 10.1186/s13613-024-01260-y
  10. Jentzer J.C., van Diepen S., Barsness G.W., et al. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. J Am Coll Cardiol. 2019; 74(17): 2117–28. DOI:10.1016/j.jacc.2019.07.077
  11. Arrigo M., Price S., Baran D.A., et al. Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop. Lancet Respir Med. 2021; 9(10): 1192–1202. DOI: 10.1016/S2213-2600(21)00172-7
  12. Warren A., McCall P., Proudfoot A., et al. EPidemiology Of Cardiogenic sHock in Scotland (EPOCHS): A multicentre, prospective observational study of the prevalence, management and outcomes of cardiogenic shock in Scotland. J Intensive Care Soc. 2023; 25(2): 147–55. DOI: 10.1177/17511437231217877
  13. Hill K.L., Rustin M.A., Asche M.A., et al. Cardiogenic Shock Classification and Associated Mortality Risk. Mayo Clin Proc. 2023; 98(5): 771–83. DOI: 10.1016/j.mayocp.2022.12.007
  14. Новосадов М.М., Новосадов В.М., Джиоева О.Н. и др. Практические аспекты оказания помощи пациентам с кардиогенным шоком. Российский кардиологический журнал. 2023; 28(1S): 5337. DOI: 10.15829/1560-4071-2023-5337 [Novosadov M.M., Novosadov V.M., Dzhioeva O.N., Drapkina O.M. Practical aspects of managing patients with cardiogenic shock. Russian Journal of Cardiology. 2023; 28(1S): 5337. DOI: 10.15829/1560-4071-2023-5337 (In Russ)]
  15. Бойцов С.А., Акчурин Р.С., Певзнер Д.В. и др. Кардиогенный шок - современное состояние проблемы. Российский кардиологический журнал, 2019; 10: 126–36. DOI: 10.15829/1560-4071-2019-10-126-136 [Boytsov S.A., Akchurin R.S., Pevzner D.V., et al. Cardiogenic shock — the current state of the problem. Russian Journal of Cardiology. 2019; 10:126–36 (In Russ)]
  16. Вышлов Е.В., Рябов В.В. Кардиогенный шок при инфаркте миокарда. Кардиология. 2019; 59(8): 64–71. DOI: 10.18087/cardio.2019.8.2631 [Vyshlov E.V., Ryabov V.V. Cardiogenic Shock in Patients with Myocardial Infarction. Kardiologiia. 2019; 59(8): 64–71 (In Russ)]
  17. Naidu S.S., Baran D.A., Jentzer J.C., et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022; 79(9): 933–46. DOI: 10.1016/j.jacc.2022.01.018
  18. Pareek N., Dworakowski R., Webb I., et al. SCAI cardiogenic shock classification after out of hospital cardiac arrest and association with outcome. Catheter Cardiovasc Interv. 2021; 97(3): e288-e297. DOI: 10.1002/ccd.28984
  19. Thiele H., Zeymer U., Neumann F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14): 1287–96. DOI: 10.1056/NEJMoa1208410
  20. Ouweneel D.M., Eriksen E., Sjauw K.D., et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017; 69(3): 278–87. DOI: 10.1016/j.jacc.2016.10.022
  21. Ingbar D.H. Cardiogenic pulmonary edema: mechanisms and treatment — an intensivist's view. Curr Opin Crit Care. 2019; 25(4): 371–8. DOI: 10.1097/MCC.0000000000000626
  22. Saxena A., Garan A.R., Kapur N.K., et al. Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation. 2020; 141(14): 1184–97. DOI: 10.1161/CIRCULATIONAHA.119.043080
  23. Zanza C., Saglietti F., Tesauro M., et al. Cardiogenic Pulmonary Edema in Emergency Medicine. Adv Respir Med. 2023; 91(5): 445–63. Published 2023 Oct 13. DOI: 10.3390/arm91050034
  24. Dobbe L., Rahman R., Elmassry M., et al. Cardiogenic Pulmonary Edema. Am J Med Sci. 2019; 358(6): 389–97. DOI: 10.1016/j.amjms.2019.09.011.
  25. Nohria A., Tsang S.W., Fang J.C., et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003; 41(10): 1797–1804. DOI: 10.1016/s0735-1097(03)00309-7
  26. Henry T.D., Tomey M.I., Tamis-Holland J.E., et al. Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2021; 143(15): e815-e829. DOI:10.1161/CIR.0000000000000959
  27. Tiwari D., Aw T.C. Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review. Diagnostics (Basel). 2023; 14(1): 87. DOI: 10.3390/diagnostics14010087
  28. Tolsma R.T., de Koning E.R., Fokkert M.J., et al. Management of patients suspected for non-ST elevation-acute coronary syndrome in the prehospital phase. Future Cardiol. 2023; 19(13): 639–47. DOI: 10.2217/fca-2023-0049
  29. Sandoval Y., Apple F.S., Mahler S.A., et al. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. Circulation. 2022; 146(7): 569–81. DOI: 10.1161/CIRCULATIONAHA.122.059678
  30. Desai S.R., Dhindsa D.S., Ko Y.A., et al. Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery Disease. Am J Cardiol. 2023; 203: 315–24. DOI:10.1016/j.amjcard.2023.06.115
  31. Maayah M., Grubman S., Allen S., et al. Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing. Diagnostics (Basel). 2024; 14(5): 503. DOI: 10.3390/diagnostics14050503
  32. Mistry N.F., Vesely M.R. Acute coronary syndromes: from the emergency department to the cardiac care unit. Cardiol Clin. 2012; 30(4): 617–27. DOI: 10.1016/j.ccl.2012.07.010
  33. McCarthy C.P., Raber I., Chapman A.R., et al. Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians. JAMA Cardiol. 2019; 4(10): 1034–42. DOI: 10.1001/jamacardio.2019.2724
  34. Ronco C., Haapio M., House A.A., et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52(19): 1527–39. DOI: 10.1016/j.jacc.2008.07.051
  35. Shirakabe A., Matsushita M., Shibata Y. et al. Organ dysfunction, injury, and failure in cardiogenic shock. J intensive care 11, 26 (2023). DOI: 10.1186/s40560-023-00676-1
  36. Shirakabe A, Hata N, Kobayashi N, et al. Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure. ESC Heart Fail. 2018; 5(3): 322–31. DOI: 10.1002/ehf2.12264
  37. Adegbala O., Inampudi C., Adejumo A., et al. Characteristics and Outcomes of Patients With Cardiogenic Shock Utilizing Hemodialysis for Acute Kidney Injury. Am J Cardiol. 2019; 123(11): 1816–21. DOI: 10.1016/j.amjcard.2019.02.038
  38. Shirakabe A., Hata N., Kobayashi N., et al. Prognostic impact of acute kidney injury in patients with acute decompensated heart failure. Circ J. 2013; 77(3): 687–96. DOI: 10.1253/circj.cj-12-0994
  39. Rogler G., Rosano G. The heart and the gut. Eur Heart J. 2014; 35(7): 426–30. DOI: 10.1093/eurheartj/eht271
  40. Sundaram V., Fang J.C. Gastrointestinal and Liver Issues in Heart Failure. Circulation. 2016; 133(17): 1696–1703. DOI: 10.1161/CIRCULATIONAHA.115.020894
  41. Fuhrmann V., Kneidinger N., Herkner H., et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011; 37(8): 1302–10. DOI: 10.1007/s00134-011-2248-7
  42. Wigger O., Bloechlinger S, Berger D, et al. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2018; 7(1): 45–52. DOI: 10.1177/2048872616683526
  43. Jentzer J.C., Schrage B., Patel P.C., et al. Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock. J Am Heart Assoc. 2022; 11(9): e024932. DOI: 10.1161/JAHA.121.024932
  44. Lazzeri C., Valente S., Chiostri M., et al. Clinical significance of lactate in acute cardiac patients. World J Cardiol. 2015; 7(8): 483–9. DOI: 10.4330/wjc.v7.i8.483
  45. Sundermeyer J., Kellner C., Beer B.N., et al. Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock. Eur J Heart Fail. 2024; 26(2): 432–44. DOI: 10.1002/ejhf.3082
  46. Nandikonda A.R., Bharathi Lakshmi V.S. Lactate clearance — A surrogate for mortality in cardiogenic shock. Indian J Cardiovasc Dis Women 2023; 8: 180–86. DOI: 10.25259/IJCDW_8_2023
  47. Soussi S., Ahmadiankalati M, Jentzer J.C., et al. Clinical phenotypes of cardiogenic shock survivors: insights into late host responses and long-term outcomes. ESC Heart Fail. 2024; 11(2): 1242–8. DOI: 10.1002/ehf2.14596
  48. Attaná P., Lazzeri C., Chiostri M., et al. Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study. Acute Card Care. 2012; 14(1): 20–6. DOI: 10.3109/17482941.2011.655293
  49. Levy B., Girerd N., Baudry G., et al. Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study. Ann Intensive Care. 2024; 14(1): 43. DOI: 10.1186/s13613-024-01266-6
  50. Сметкин А.А., Киров М.Ю. Мониторинг венозной сатурации в анестезиологии и интенсивной терапии. Общая реаниматология. 2008; 4(4): 86. DOI: 10.15360/1813-9779-2008-4-86 [Smetkin A.A., Kirov M.Yu. Venous Saturation Monitoring in Anesthesiology and Intensive Care. General Reanimatology. 2008; 4(4): 86 (In Russ)]
  51. Simmons J., Ventetuolo C.E. Cardiopulmonary monitoring of shock. Curr Opin Crit Care. 2017; 23(3): 223–31. DOI: 10.1097/MCC.0000000000000407
  52. Shah N.R., Bieniarz M.C., Basra S.S., et al. Serum biomarkers in severe refractory cardiogenic shock. JACC HeartFail. 2013; 1: 200–06
  53. van Beest P., Wietasch G., Scheeren T., et al. Clinical review: use of venous oxygen saturations as a goal — a yet unfinished puzzle. Crit Care. 2011; 15(5): 232. DOI: 10.1186/cc10351
  54. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002; 347(3): 161–7. DOI:10.1056/NEJMoa020233
  55. Januzzi J.L.Jr., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005; 95(8): 948–54. DOI:10.1016/j.amjcard.2004.12.032
  56. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002; 106(4): 416–22. DOI: 10.1161/01.cir.0000025242.79963.4c
  57. Januzzi J.L.Jr., Chen-Tournoux A.A., Christenson R.H., et al. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. J Am Coll Cardiol. 2018; 71(11): 1191–1200. DOI: 10.1016/j.jacc.2018.01.021
  58. Yancy C.W., Jessup M., Bozkurt B., et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology /American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017; 70(6): 776–803. DOI: 10.1016/j.jacc.2017.04.025
  59. Iborra-Egea O., Montero S., Bayes-Genis A. An outlook on biomarkers in cardiogenic shock. Curr Opin Crit Care. 2020; 26(4): 392–7. DOI: 10.1097/MCC.0000000000000739
  60. Wettersten N. Biomarkers in Acute Heart Failure: Diagnosis, Prognosis, and Treatment. Int J Heart Fail. 2021; v3(2): 81–105. DOI: 10.36628/ijhf.2020.0036
  61. Козлов И.А., Соколов Д.А. Оценка биомаркера напряжения миокарда NT-proBNP в реальной клинической практике. Общая реаниматология. 2023; 19(1); 4–12. DOI: 10.15360/1813-9779-2023-1-2272 [Kozlov I.A., Sokolov D.A. Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice. General Reanimatology. 2023; 19(1): 4–12 (In Russ)]
  62. Российское кардиологическое общество (РКО) Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(11): 4103. DOI: 10.15829/29/1560-4071-2020-4103 [2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020; 25(11): 4103. DOI: 10.15829/1560-4071-2020-4103 (In Russ)]
  63. Douglas P.S., Khandheria B., Stainback R.F., et al. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: J Am Coll Cardiol. 2007 Jul 10; 50(2): 187–204. DOI: 10.1016/j.jacc.2007.05.003
  64. Okutucu S., Fatihoglu S.G., Lacoste M.O., et al. Echocardiographic assessment in cardiogenic shock. Herz. 2021 Oct; 46(5): 467–75. English. DOI: 10.1007/s00059-020-05000-3
  65. Porter T.R., Shillcutt S.K., Adams M.S., et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2025: 28(1): 40–56. DOI: 10.1016/j.echo.2014.09.009
  66. Singam N.S.V., Tabi M., Wiley B., et al. Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure. Int J Cardiol. 2023 Aug 1; 384: 38–47. DOI: 10.1016/j.ijcard.2023.04.041
  67. Bora V., Pulijal S.V. Transesophageal Echocardiography in Critical Care. Curr Pulmonol Rep (2024). DOI: 10.1007/s13665-024-00351-2
  68. Заболотских И.Б., Григорьев Е.В., Афончиков В.С и др. Гиповолемический шок у взрослых. Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов». Вестник интенсивной терапии им. А.И. Салтанова. 2024; 4: 7–39. DOI: 10.21320/1818-474X-2024-4-7-39 [Zabolotskikh I.B., Grigoryev E.V, Afonchikov V.S., et al. Hypovolemic shock in adults. Guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists”. Annals of Critical Care. 2024; 4:7–39. DOI: 10.21320/1818-474X-2024-4-7-3 (In Russ)]
  69. Cecconi M., De Backer D., Antonelli M., et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014; 40(12): 1795–1815. DOI: 10.1007/s00134-014-3525-z
  70. Osman M., Syed M., Patel B., et al. Invasive hemodynamic monitoring in cardiogenic shock is associated with lower in-hospital mortality. J Am Heart Assoc. 2021; 10(18). DOI: 10.1161/JAHA.121.021808
  71. Burstein B., Tabi M., Barsness G.W., et al. Association between mean arterial pressure during the first 24 h and hospital mortality in patients with cardiogenic shock. Crit Care. 2020; 24(1): 513. DOI: 10.1186/s13054-020-03217-6
  72. Lim H.S. Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization. Clin Cardiol. 2016 Aug; 39(8): 477–83. DOI: 10.1002/clc.22564
  73. Cavaliere F., Giovannini I., Chiarla C., et al. Comparison of two methods to assess blood CO2 equilibration curve in mechanically ventilated patients. Respir Physiol Neurobiol. 2005;146(1): 77–83. DOI: 10.1016/j.resp.2004.11.008
  74. Vallée F., Vallet B., Mathe O., et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock. Intensive Care Med. 2008; 34(12): 2218–25. DOI: 10.1007/s00134-008-1199-0
  75. Sepehrvand N., Ezekowitz J.A. Oxygen Therapy in Patients With Acute Heart Failure. JACC Hear Fail 2016; 4: 783–90.
  76. Ramachandran G., Prasad C.H.R.K., Garre S., et al. Oxygen Management in Heart Failure Patients. Indian Journal of Clinical Cardiology. 2022; 3(3): 150–6. DOI:10.1177/26324636221081585
  77. Hofmann R., James S.K., Jernberg T., et al. Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017; 377: 1240–9.
  78. Rochwerg B., Brochard L., Elliott M.W., et al. Members Of The Steering Committee, Antonelli M., Brozek J., Conti G., Ferrer M., Guntupalli K., Jaber S., Keenan S., Mancebo J., Mehta S., Raoof S. Members Of The Task Force. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017 Aug 31; 50(2): 1602426. DOI: 10.1183/13993003.02426-2016
  79. Masip J., Betbesé A.J., Páez J., et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet. 2000 Dec 23–30; 356(9248): 2126–32. DOI: 10.1016/s0140-6736(00)03492-9
  80. Masip J., Peacock W.F., Price S., et al. Acute Heart Failure Study Group of the Acute Cardiovascular Care Association and the Committee on Acute Heart Failure of the Heart Failure Association of the European Society of Cardiology, Indications and practical approach to non-invasive ventilation in acute heart failure, European Heart Journal, Volume 39, Issue 1, 01 January 2018, Pages 17–25. DOI: 10.1093/eurheartj/ehx580
  81. Alviar C.L., Rico-Mesa J.S., Morrow D.A., et al. Positive Pressure Ventilation in Cardiogenic Shock: Review of the Evidence and Practical Advice for Patients With Mechanical Circulatory Support. Can J Cardiol. 2020 Feb; 36(2): 300–12. DOI: 10.1016/j.cjca.2019.11.038
  82. Weng C.-L. Meta-analysis: Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema. Ann Intern Med 2010; 152: 590.
  83. Gray A., Goodacre S., Newby D., et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oe. Health Technol Assess (Rockv) 2009; 13. DOI: 10.3310/hta13330
  84. Vital F.M., Ladeira M.T., Atallah Á.N. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 2013. DOI: 10.1002/14651858.CD005351.pub3
  85. Park M., Sangean M.C., Volpe M. de S., et al. Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med 2004; 32: 2407–2241.
  86. Gray A., Goodacre S., Newby D.E., et al. Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema. N Engl J Med 2008; 359: 142–15.
  87. Makdee O., Monsomboon A., Surabenjawong U., et al. High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Emergency Department Patients With Cardiogenic Pulmonary Edema: A Randomized Controlled Trial. Ann Emerg Med 2017; 70: 465–72.e2.
  88. Lewis S.R., Baker P.E., Parker R., et al. High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst Rev 2017 DOI: 10.1002/14651858.CD010172.pub2
  89. Mebazaa A., Yilmaz M.B., Levy P., et al. Recommendations on pre-hospital; early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emer. Eur J Heart Fail 2015; 17: 544–58.
  90. Kuhn B.T., Bradley L.A., Dempsey T.M., et al. Management of Mechanical Ventilation in Decompensated Heart Failure. J Cardiovasc Dev Dis. 2016 Dec 2; 3(4): 33. DOI: 10.3390/jcdd3040033
  91. Pinsky M.R. Cardiopulmonary Interactions: Physiologic Basis and Clinical Applications. Ann Am Thorac Soc. 2018 Feb;15(Suppl 1): S45–S48. DOI: 10.1513/AnnalsATS.201704-339FR
  92. Alvarado A.C., Pinsky M.R. Cardiopulmonary interactions in left heart failure. Front Physiol. 2023 Aug 8; 14: 1237741. DOI: 10.3389/fphys.2023.1237741
  93. Price L.C., Wort S.J., Finney S.J., et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 2010; 14: R169.
  94. Simonis F.D., Serpa Neto A., Binnekade J.M., et al. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS. JAMA 2018; 320: 1872.
  95. Wiesen J., Ornstein M., Tonelli A.R., et al. State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shock. Heart 2013; 99: 1812–17.GRACE MP, GREENBAUM DM. Cardiac performance in response to PEEP in patients with cardiac dysfunction. Crit Care Med 1982; 10: 358–360.
  96. Liu H., Wu X., Zhao X., et al. Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis. J Int Med Res 2016; 44: 433–43.
  97. Levy B., Clere-Jehl R., Legras A., et al. Collaborators. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2018 Jul 10; 72(2): 173–82. DOI: 10.1016/j.jacc.2018.04.051. PMID: 29976291
  98. Léopold V., Gayat E., Pirracchio R., et al. Correction to: Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med. 2018 Nov; 44(11): 2022–3. DOI: 10.1007/s00134-018-5372-9. Erratum for: Intensive Care Med. 2018 Jun; 44(6): 847–56
  99. Kemp S.F., Lockey R.F., Simons F.E.R. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008; 63: 1061–70.
  100. Senz A., Nunnink L. Review article: inotrope and vasopressor use in the emergency department. Emerg Med Australas 2009; 21: 342–51.
  101. Shankar A., Gurumurthy G., Sridharan L., et al. Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock. Clin Med Insights Cardiol. 2022 Feb 7; 16: 11795468221075064. DOI: 10.1177/11795468221075064
  102. Amado J., Gago P., Santos W., et al. Cardiogenic shock: Inotropes and vasopressors. Rev Port Cardiol. 2016 Dec; 35(12): 681–95. English, Portuguese. DOI: 10.1016/j.repc.2016.08.004
  103. Polyzogopoulou E., Arfaras-Melainis A., Bistola V., Parissis J. Inotropic agents in cardiogenic shock. Curr Opin Crit Care. 2020 Aug; 26(4): 403–10. DOI: 10.1097/MCC.0000000000000744
  104. De Backer D., Arias Ortiz J., Levy B. The medical treatment of cardiogenic shock: cardiovascular drugs. Curr Opin Crit Care. 2021 Aug 1; 27(4): 426–32. DOI: 10.1097/MCC.0000000000000822
  105. Schumann J., Henrich E.C., Strobl H., et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018 Jan 29; 1(1): CD009669. DOI: 10.1002/14651858.CD009669.pub3. Update in: Cochrane Database Syst Rev. 2020 Nov 5; 11:CD009669
  106. Shabana A., Dholoo F., Banerjee P. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock. Curr Heart Fail Rep. 2020 Dec; 17(6) :438–48. DOI: 10.1007/s11897-020-00493-9
  107. Tarvasmäki T., Lassus J., Varpula M., et al. CardShock study investigators. Current real-life use of vasopressors and inotropes in cardiogenic shock — adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016 Jul 4; 20(1): 208. DOI: 10.1186/s13054-016-1387-1
  108. Abdel-Razek O., Di Santo P., Jung R.G., et al. Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis. Crit Care Explor. 2023 Aug 28; 5(9): e0962. DOI: 10.1097/CCE.0000000000000962
  109. Lozada Martinez I.D., Bayona-Gamboa A.J., Meza-Fandiño D.F., et al. Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine? Ann Med Surg (Lond). 2022 Sep 22; 82: 104763. DOI: 10.1016/j.amsu.2022.104763
  110. Mathew R., Di Santo P., Jung R.G., et al. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. N Engl J Med. 2021 Aug 5; 385(6): 516–25. DOI: 10.1056/NEJMoa2026845
  111. MacGregor D.A., Smith T.E., Prielipp R.C., et al. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology. 2000 Feb; 92(2): 338–46. DOI: 10.1097/00000542-200002000-00013
  112. Amin A., Maleki M. Positive inotropes in heart failure: a review article. Heart Asia. 2012 Jan 1; 4(1): 16–22. DOI: 10.1136/heartasia-2011-010068
  113. Petersen J.W., Felker G.M. Inotropes in the management of acute heart failure. Crit Care Med. 2008 Jan; 36 (1 Suppl): S106–111. DOI: 10.1097/01.CCM.0000296273.72952.39
  114. Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362: 779–89.
  115. Еременко А.А., Бабаев М.А. Мезатон или норадреналин при лечении послеоперационной сердечно-сосудистой недостаточности у кардиохирургичских больных? Вестник интенсивной терапии. 2009; 1: 18–20. [Eremenko A.A., Babaev M.A. Mezaton ili noradrenalin pri lechenii posleoperacionnoj serdechno-sosudistoj nedostatochnosti u kardiohirurgichskih bol'nyh? Annals of Critical Care. 2009; 1: 18–20 (In Russ)]
  116. Bloom J.E., Chan W., Kaye D.M., et al. State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock. J Am Heart Assoc. 2023; 12(15): e029787. DOI: 10.1161/JAHA.123.029787
  117. Basir M.B., Lemor A., Gorgis S., et al. Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock. Catheter Cardiovasc Interv. 2022; 99(3): 650–7. DOI: 10.1002/ccd.29895
  118. Jolly S., Newton G., Horlick E., et al. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2005; 96(12): 1617–20. DOI: 10.1016/j.amjcard.2005.07.076
  119. Conti N., Gatti M., Raschi E., et al. Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap. Drug Des Devel Ther. 2021; 15: 3391–3409. DOI:10.2147/DDDT.S295214
  120. Papp Z., Agostoni P., Alvarez J., et al. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use. J Cardiovasc Pharmacol. 2020; 76(1): 4–22. DOI: 10.1097/FJC.0000000000000859
  121. Buerkem B., Lemm H., Krohe K., et al. Levosimendan in the treatment of cardiogenic shock. Minerva Cardioangiol. 2010; 58(4): 519–30.
  122. Fuhrmann J.T., Schmeisser A., Schulze M.R., et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2008; 36(8): 2257–66. DOI: 10.1097/CCM.0b013e3181809846
  123. Rijnders B.J. Evaluation of 30-day mortality of levosimendan versus enoximone. Crit Care Med. 2009; 37(3): 1181–2. DOI: 10.1097/CCM.0b013e3181959b4e
  124. Tsagalou E.P., Kanakakis J., Anastasiou-Nana M.I., et al. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute Card Care. 2009; 11(2): 99–106. DOI: 10.1080/17482940902807286
  125. Thiele H., Zeymer U., Neumann F.J., et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382(9905): 1638–45. DOI: 10.1016/S0140-6736(13)61783-3
  126. Unverzagt S., Buerke M., de Waha A., et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015; 2015(3): CD007398. DOI: 10.1002/14651858.CD007398.pub3
  127. Neumann F.J., Sousa-Uva M., Ahlsson A., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165. DOI: 10.1093/eurheartj/ehy394
  128. Rajsic S., Treml B., Jadzic D., et al. Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications. Ann Intensive Care. 2022; 12(1): 93. DOI: 10.1186/s13613-022-01067-9
  129. Fux T., Holm M., Corbascio M., et al. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality. J Thorac Cardiovasc Surg. 2018; 156(5): 1894–1902.e3. DOI: 10.1016/j.jtcvs.2018.05.061
  130. Choi K.H., Yang J.H., Hong D., et al. Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic Shock. Circ J. 2020; 84(9): 1502–1510. DOI: 10.1253/circj.CJ-20-0259
  131. Treml B., Breitkopf R., Bukumirić Z., et al. ECMO Predictors of Mortality: A 10-Year Referral Centre Experience. J Clin Med. 2022; 11(5): 1224. DOI: 10.3390/jcm11051224
  132. Oude Lansink-Hartgring A., de Vries A.J., Droogh J.M., et al. Hemorrhagic complications during extracorporeal membrane oxygenation — The role of anticoagulation and platelets. J Crit Care. 2019; 54: 239–243. DOI: 10.1016/j.jcrc.2019.09.013
  133. Ouweneel D.M., Schotborgh J.V., Limpens J., et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med. 2016; 42(12): 1922–1934. DOI: 10.1007/s00134-016-4536-8
  134. Sandrio S., Krebs J., Leonardy E., et al. Vasoactive Inotropic Score as a Prognostic Factor during (Cardio-) Respiratory ECMO. J Clin Med. 2022; 11(9): 2390. DOI: 10.3390/jcm11092390
  135. Hyun J., Kim A.R., Lee S.E., et al. Vasoactive-Inotropic Score as a Determinant of Timely Initiation of Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. Circ J. 2022; 86(4): 687–694. DOI: 10.1253/circj.CJ-21-0614
  136. Thiele H., Jobs A., Ouweneel D.M., et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017; 38(47): 3523–3531. DOI: 10.1093/eurheartj/ehx363
  137. Dhruva S.S., Ross J.S., Mortazavi B.J., et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA. 2020; 323(8): 734–745. DOI: 10.1001/jama.2020.0254
  138. O'Neill W.W., Kleiman N.S., Moses J., et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012; 126(14): 1717–1727. DOI: 10.1161/CIRCULATIONAHA.112.098194
  139. Acharya D., Loyaga-Rendon R.Y., Pamboukian S.V., et al. Ventricular Assist Device in Acute Myocardial Infarction. J Am Coll Cardiol. 2016; 67(16): 1871–1880 DOI:10.1016/j.jacc.2016.02.025
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2025 Annals of Critical Care

Most read articles by the same author(s)

<< < 1 2 3 4